Your browser doesn't support javascript.
loading
Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages.
Nyberg, Tommy; Harman, Katie; Zaidi, Asad; Seaman, Shaun R; Andrews, Nick; Nash, Sophie G; Charlett, Andre; Lopez Bernal, Jamie; Myers, Richard; Groves, Natalie; Gallagher, Eileen; Gharbia, Saheer; Chand, Meera; Thelwall, Simon; De Angelis, Daniela; Dabrera, Gavin; Presanis, Anne M.
Afiliación
  • Nyberg T; Medical Research Council Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.
  • Harman K; COVID-19 National Epidemiology Cell, UK Health Security Agency, London, United Kingdom.
  • Zaidi A; COVID-19 National Epidemiology Cell, UK Health Security Agency, London, United Kingdom.
  • Seaman SR; Medical Research Council Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.
  • Andrews N; Immunisation and Countermeasures Division, UK Health Security Agency, London, United Kingdom.
  • Nash SG; COVID-19 National Epidemiology Cell, UK Health Security Agency, London, United Kingdom.
  • Charlett A; National Infection Service, UK Health Security Agency, London, United Kingdom.
  • Lopez Bernal J; Immunisation and Countermeasures Division, UK Health Security Agency, London, United Kingdom.
  • Myers R; Genomics Cell, UK Health Security Agency, London, United Kingdom.
  • Groves N; Genomics Cell, UK Health Security Agency, London, United Kingdom.
  • Gallagher E; Genomics Cell, UK Health Security Agency, London, United Kingdom.
  • Gharbia S; Genomics Programme, UK Health Security Agency, London, United Kingdom.
  • Chand M; Genomics Cell, UK Health Security Agency, London, United Kingdom.
  • Thelwall S; COVID-19 National Epidemiology Cell, UK Health Security Agency, London, United Kingdom.
  • De Angelis D; Medical Research Council Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.
  • Dabrera G; COVID-19 National Epidemiology Cell, UK Health Security Agency, London, United Kingdom.
  • Presanis AM; Medical Research Council Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.
J Infect Dis ; 226(5): 808-811, 2022 09 13.
Article en En | MEDLINE | ID: mdl-35184201
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido